- Goulston & Storrs, PC provided legal counsel to Abacus
- Summit Clinical Research was founded in 2018
- Abacus Finance targets private debt financing opportunities of up to $50 million and finances companies with EBITDA between $3 million and $15 million
Lender Abacus Finance Group has provided senior debt financing to back LongueVue Capital‘s buyout of Summit Clinical Research, a San Antonio, Texas-based research organization focused on hepatology. No financial terms were disclosed.
Abacus made an equity co-investment in SCR. Abacus served as administrative agent and sole lender on the financing.
Legal counsel was provided to Abacus by Goulston & Storrs, PC.
“Once again, great work by the Abacus team,” said LongueVue Partner Ryan Nagim in a statement. “They know the sector well, and the result was a smoothly executed transaction, which is their hallmark.”
Summit Clinical Research was founded in 2018.
Founded in 2001, LongueVue Capital invests in a number of sectors that include specialty manufacturing, transportation and logistics, healthcare, business and industrial services, and food and beverage.
Abacus Finance targets private debt financing opportunities of up to $50 million and finances companies with EBITDA between $3 million and $15 million.